The clinical presentation of Ehlers-Danlos syndrome
- PMID: 16338669
- DOI: 10.1016/j.adnc.2005.09.006
The clinical presentation of Ehlers-Danlos syndrome
Abstract
Ehlers-Danlos syndrome (EDS), a heterogeneous group of inheritable connective tissue disorders, is attributed to mutations in connective tissue genes. These mutations cause defects in collagen. Collagen, a connective tissue protein that acts like glue, gives strength to the body and provides support and elasticity for movement. Thus, the altered gene affects the mechanical properties of skin, joints, ligaments, and blood vessels. Ehlers-Danlos syndrome is transmitted through autosomal dominant, autosomal recessive, or x-linked patterns of inheritance. The life expectancy of an affected infant varies with the type of EDS. This article provides an overview of the 6 major classifications of EDS, their unique clinical presentations, a focused physical assessment guide, considerations for nursing care, and resources for parents. Ehlers-Danlos syndrome can be a potentially debilitating syndrome. It requires preventative and protective measures starting at birth to preserve joint function to improve infant outcomes. Caring for patients with EDS requires an understanding of the potential associated complications to help minimize the physical and emotional impact of the syndrome and improve the quality of life for affected individuals.
Similar articles
-
Ehlers-Danlos Syndrome, classical type: case management.Pediatr Nurs. 2003 Nov-Dec;29(6):423-6. Pediatr Nurs. 2003. PMID: 14743836 Review.
-
Ehlers-Danlos syndromes and Marfan syndrome.Best Pract Res Clin Rheumatol. 2008 Mar;22(1):165-89. doi: 10.1016/j.berh.2007.12.005. Best Pract Res Clin Rheumatol. 2008. PMID: 18328988 Review.
-
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.N Engl J Med. 2001 Oct 18;345(16):1167-75. doi: 10.1056/NEJMoa002939. N Engl J Med. 2001. PMID: 11642233
-
Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.Mol Genet Metab. 2000 Sep-Oct;71(1-2):212-24. doi: 10.1006/mgme.2000.3076. Mol Genet Metab. 2000. PMID: 11001813 Review.
-
Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations.Clin Genet. 2005 Apr;67(4):330-4. doi: 10.1111/j.1399-0004.2005.00401.x. Clin Genet. 2005. PMID: 15733269
Cited by
-
Proprioceptive sensitivity in Ehlers-Danlos syndrome patients.Exp Brain Res. 2013 Oct;230(3):311-21. doi: 10.1007/s00221-013-3656-4. Epub 2013 Aug 3. Exp Brain Res. 2013. PMID: 23912909
-
Central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome-a feasibility study.Pilot Feasibility Stud. 2023 Jun 14;9(1):97. doi: 10.1186/s40814-023-01320-3. Pilot Feasibility Stud. 2023. PMID: 37316864 Free PMC article.
-
From the Sea to the Skin: Exploring Dermatological Eponyms Inspired by Aquatic Animals.Indian Dermatol Online J. 2025 Apr 1;16(4):612-616. doi: 10.4103/idoj.idoj_692_24. eCollection 2025 Jul-Aug. Indian Dermatol Online J. 2025. PMID: 40688142 Free PMC article. No abstract available.
-
Single-level posterior lumbar fusions in patients with Ehlers Danlos Syndrome not found to be associated with increased postoperative adverse events or five-year reoperations.N Am Spine Soc J. 2022 Jun 22;11:100136. doi: 10.1016/j.xnsj.2022.100136. eCollection 2022 Sep. N Am Spine Soc J. 2022. PMID: 35783003 Free PMC article.
-
Indications and Outcomes After Ligamentum Teres Reconstruction: A Systematic Review.Arthrosc Sports Med Rehabil. 2021 May 7;3(3):e939-e949. doi: 10.1016/j.asmr.2021.01.023. eCollection 2021 Jun. Arthrosc Sports Med Rehabil. 2021. PMID: 34195664 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical